Best Biotech Stocks to Buy Now (2024)Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.
Industry: Biotechnology
| Ticker | Company | Forecast Score | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $2.55B | $24.52 | $40.67 | 65.85% | Strong Buy | 3 | 13.45% | 24.89% | N/A | N/A | ||||
| INCY | INCYTE CORP | $12.07B | $53.76 | $74.92 | 39.37% | Buy | 13 | 10.20% | 41.93% | N/A | N/A | ||||
| AMLX | AMYLYX PHARMACEUTICALS INC | $137.60M | $2.03 | $11.00 | 441.87% | Buy | 5 | -49.09% | 142.34% | N/A | N/A | ||||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.79B | $31.57 | $39.80 | 26.07% | Hold | 5 | 15.57% | 38.33% | N/A | N/A | ||||
| PBYI | PUMA BIOTECHNOLOGY INC | $234.44M | $4.86 | $7.00 | 44.03% | Buy | 1 | 2.22% | 67.87% | N/A | N/A | ||||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $15.65B | $82.44 | $100.90 | 22.39% | Buy | 10 | 11.14% | 81.99% | N/A | N/A | ||||
| EXEL | EXELIXIS INC | $6.38B | $21.90 | $27.25 | 24.43% | Buy | 8 | 7.84% | 56.43% | N/A | N/A | ||||
| VYGR | VOYAGER THERAPEUTICS INC | $478.39M | $8.81 | $20.50 | 132.69% | Strong Buy | 4 | -25.11% | N/A | N/A | N/A | ||||
| HALO | HALOZYME THERAPEUTICS INC | $5.06B | $39.91 | $54.17 | 35.72% | Buy | 6 | 15.95% | 48.53% | N/A | N/A | ||||
| GMAB | GENMAB A | $19.65B | $29.72 | $45.00 | 51.41% | Buy | 4 | 19.26% | 37.91% | N/A | N/A | ||||
| UTHR | UNITED THERAPEUTICS CORP | $11.64B | $262.40 | $317.17 | 20.87% | Buy | 6 | 7.07% | 6.59% | N/A | N/A | ||||
| TGTX | TG THERAPEUTICS INC | $2.50B | $16.19 | $31.20 | 92.71% | Strong Buy | 5 | 37.42% | 139.09% | N/A | N/A | ||||
| ROIV | ROIVANT SCIENCES LTD | $9.18B | $11.39 | $17.11 | 50.23% | Strong Buy | 9 | 76.07% | N/A | N/A | N/A | ||||
| RPRX | ROYALTY PHARMA PLC | $16.97B | $28.41 | $46.75 | 64.55% | Strong Buy | 4 | 11.31% | 34.87% | N/A | N/A | ||||
| MEIP | MEI PHARMA INC | $20.39M | $3.06 | $7.00 | 128.76% | Hold | 1 | -42.12% | N/A | N/A | N/A | ||||
| BNTX | BIONTECH SE | $22.04B | $92.72 | $114.71 | 23.72% | Hold | 7 | -10.54% | 36.84% | N/A | N/A | ||||
| MDXG | MIMEDX GROUP INC | $1.09B | $7.37 | $12.33 | 67.34% | Strong Buy | 3 | 14.13% | 14.96% | N/A | N/A | ||||
| REGN | REGENERON PHARMACEUTICALS INC | $105.45B | $957.00 | $1.02k | 6.19% | Buy | 14 | 7.46% | 5.74% | N/A | N/A | ||||
| VNDA | VANDA PHARMACEUTICALS INC | $280.78M | $4.88 | N/A | N/A | N/A | N/A | 13.15% | 102.06% | N/A | N/A | ||||
| SRPT | SAREPTA THERAPEUTICS INC | $12.63B | $133.66 | $161.33 | 20.70% | Strong Buy | 12 | 27.65% | 153.38% | N/A | N/A | ||||
| SPRO | SPERO THERAPEUTICS INC | $87.81M | $1.63 | $7.00 | 329.45% | Buy | 1 | -31.99% | N/A | N/A | N/A | ||||
| AVRO | AVROBIO INC | $54.73M | $1.22 | $2.00 | 63.93% | Hold | 1 | N/A | N/A | N/A | N/A | ||||
| BNOX | BIONOMICS LIMITED | $11.09M | $0.96 | $8.00 | 733.33% | Buy | 1 | 22,893.66% | N/A | -45,044.89% | -33,660.38% | ||||
| VRTX | VERTEX PHARMACEUTICALS INC | $103.60B | $401.08 | $451.75 | 12.63% | Buy | 16 | 8.93% | 2.45% | N/A | N/A | ||||
| KRYS | KRYSTAL BIOTECH INC | $4.56B | $161.10 | $185.67 | 15.25% | Strong Buy | 6 | 104.18% | 52.91% | N/A | N/A | ||||
| CPRX | CATALYST PHARMACEUTICALS INC | $1.73B | $14.72 | $27.40 | 86.14% | Strong Buy | 5 | 16.35% | 16.52% | N/A | N/A | ||||
| CRSP | CRISPR THERAPEUTICS AG | $4.49B | $55.89 | $84.00 | 50.30% | Buy | 11 | 52.20% | N/A | N/A | N/A | ||||
| TFFP | TFF PHARMACEUTICALS INC | $5.11M | $2.03 | $44.00 | 2,067.49% | Strong Buy | 1 | 136.51% | N/A | N/A | N/A | ||||
| KNSA | KINIKSA PHARMACEUTICALS LTD | $1.42B | $20.08 | $29.75 | 48.16% | Strong Buy | 4 | 26.86% | N/A | N/A | N/A | ||||
| OCUP | OCUPHIRE PHARMA INC | $49.38M | $1.99 | $20.00 | 905.03% | Strong Buy | 2 | 46.92% | N/A | N/A | N/A | ||||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $83.28M | $1.14 | $10.00 | 777.19% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| SEER | SEER INC | $145.09M | $2.24 | N/A | N/A | N/A | N/A | 39.00% | N/A | N/A | N/A | ||||
| ADAG | ADAGENE INC | $106.32M | $2.41 | N/A | N/A | N/A | N/A | 37.92% | N/A | N/A | N/A | ||||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $6.93B | $110.01 | $190.55 | 73.21% | Strong Buy | 11 | 6.58% | 77.12% | N/A | N/A | ||||
| MIRM | MIRUM PHARMACEUTICALS INC | $1.21B | $25.84 | $52.75 | 104.14% | Strong Buy | 8 | 45.39% | N/A | N/A | N/A | ||||
| IMMP | IMMUTEP LTD | $335.25M | $2.82 | N/A | N/A | N/A | N/A | 452.47% | N/A | N/A | N/A | ||||
| VYNE | VYNE THERAPEUTICS INC | $36.94M | $2.62 | $5.75 | 119.47% | Buy | 1 | 479.50% | N/A | N/A | N/A | ||||
| DBVT | DBV TECHNOLOGIES SA | $128.64M | $0.67 | $10.00 | 1,399.25% | Buy | 1 | 166.59% | N/A | N/A | N/A | ||||
| PRTA | PROTHENA CORP PUBLIC LTD CO | $1.23B | $22.93 | $68.14 | 197.18% | Buy | 7 | 34.72% | N/A | N/A | N/A | ||||
| IDYA | IDEAYA BIOSCIENCES INC | $3.14B | $42.18 | $52.14 | 23.62% | Strong Buy | 7 | 46.64% | N/A | N/A | N/A | ||||
| CLGN | COLLPLANT BIOTECHNOLOGIES LTD | $68.14M | $5.95 | $11.00 | 84.87% | Buy | 1 | 28.53% | N/A | N/A | N/A | ||||
| RNA | AVIDITY BIOSCIENCES INC | $2.11B | $26.45 | $43.60 | 64.84% | Strong Buy | 5 | 178.46% | N/A | N/A | N/A | ||||
| VTGN | VISTAGEN THERAPEUTICS INC | $121.61M | $4.50 | $13.50 | 200.00% | Strong Buy | 2 | 109.58% | N/A | N/A | N/A | ||||
| LPCN | LIPOCINE INC | $24.88M | $4.68 | N/A | N/A | N/A | N/A | N/A | N/A | 39.93% | 35.36% | ||||
| ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC | $733.98M | $27.27 | $63.25 | 131.94% | Strong Buy | 4 | 77.03% | N/A | N/A | N/A | ||||
| ORMP | ORAMED PHARMACEUTICALS INC | $95.22M | $2.35 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| INM | INMED PHARMACEUTICALS INC | $1.47M | $0.24 | N/A | N/A | N/A | N/A | 78.42% | N/A | -237.12% | -198.52% | ||||
| ALGS | ALIGOS THERAPEUTICS INC | $61.29M | $0.81 | N/A | N/A | N/A | N/A | 235.91% | N/A | N/A | N/A | ||||
| KZR | KEZAR LIFE SCIENCES INC | $62.39M | $0.86 | $11.00 | 1,183.55% | Buy | 2 | 47.18% | N/A | N/A | N/A | ||||
| GNFT | GENFIT SA | $182.40M | $3.66 | $11.00 | 200.55% | Buy | 1 | 23.22% | N/A | N/A | N/A | ||||
| MDWD | MEDIWOUND LTD | $171.99M | $18.65 | $28.00 | 50.13% | Buy | 1 | 39.36% | N/A | N/A | N/A | ||||
| ZYME | ZYMEWORKS INC | $650.48M | $9.20 | $12.67 | 37.68% | Strong Buy | 3 | 43.59% | N/A | N/A | N/A | ||||
| ANIX | ANIXA BIOSCIENCES INC | $93.79M | $2.94 | $12.00 | 308.16% | Buy | 1 | 1,188.83% | N/A | N/A | N/A | ||||
| AXSM | AXSOME THERAPEUTICS INC | $3.54B | $74.80 | $125.73 | 68.08% | Strong Buy | 11 | 53.06% | N/A | N/A | N/A | ||||
| LEGN | LEGEND BIOTECH CORP | $8.26B | $45.41 | $82.86 | 82.46% | Strong Buy | 7 | 85.32% | N/A | N/A | N/A | ||||
| NVO | NOVO NORDISK A S | $554.96B | $123.05 | $133.00 | 8.09% | Strong Buy | 6 | 19.15% | 2.84% | N/A | N/A | ||||
| AGIO | AGIOS PHARMACEUTICALS INC | $1.96B | $34.54 | $35.00 | 1.33% | Hold | 3 | 84.45% | N/A | N/A | N/A | ||||
| PTGX | PROTAGONIST THERAPEUTICS INC | $1.52B | $26.09 | $39.00 | 49.48% | Strong Buy | 3 | 34.38% | N/A | N/A | N/A | ||||
| FULC | FULCRUM THERAPEUTICS INC | $480.00M | $7.75 | $13.00 | 67.74% | Buy | 4 | 218.27% | N/A | N/A | N/A | ||||
| XCUR | EXICURE INC | $4.33M | $0.50 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| MRUS | MERUS NV | $2.80B | $48.36 | $64.60 | 33.58% | Strong Buy | 5 | 43.95% | N/A | N/A | N/A | ||||
| FUSN | FUSION PHARMACEUTICALS INC | $1.82B | $21.45 | $20.25 | -5.59% | Hold | 8 | 96.93% | N/A | N/A | N/A | ||||
| ACIU | AC IMMUNE SA | $237.08M | $2.39 | $16.00 | 569.46% | Buy | 1 | 89.72% | N/A | N/A | N/A | ||||
| FATE | FATE THERAPEUTICS INC | $402.90M | $4.06 | $7.13 | 75.49% | Hold | 8 | 92.56% | N/A | N/A | N/A | ||||
| ARGX | ARGENX SE | $22.98B | $388.20 | $511.67 | 31.80% | Strong Buy | 15 | 339.17% | N/A | N/A | N/A | ||||
| XBIO | XENETIC BIOSCIENCES INC | $6.58M | $4.27 | N/A | N/A | N/A | N/A | -6.64% | N/A | N/A | N/A | ||||
| SLGL | SOL-GEL TECHNOLOGIES LTD | $23.68M | $0.85 | $9.00 | 958.82% | Buy | 1 | 75.66% | N/A | N/A | N/A | ||||
| CLNN | CLENE INC | $55.87M | $0.44 | $6.00 | 1,279.31% | Strong Buy | 2 | 103.75% | N/A | N/A | N/A | ||||
| JANX | JANUX THERAPEUTICS INC | $3.35B | $64.78 | $58.14 | -10.25% | Strong Buy | 7 | 131.99% | N/A | N/A | N/A | ||||
| IGMS | IGM BIOSCIENCES INC | $591.98M | $10.07 | $15.67 | 55.58% | Buy | 6 | 250.10% | N/A | N/A | N/A | ||||
| VERV | VERVE THERAPEUTICS INC | $536.00M | $6.41 | $37.50 | 485.02% | Strong Buy | 2 | 16.20% | N/A | N/A | N/A | ||||
| TRAW | TRAWS PHARMA INC | $13.38M | $0.64 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| MRKR | MARKER THERAPEUTICS INC | $37.57M | $4.22 | $11.00 | 160.66% | Strong Buy | 1 | 272.67% | N/A | N/A | N/A | ||||
| ZVRA | ZEVRA THERAPEUTICS INC | $208.88M | $4.81 | $15.00 | 211.85% | Buy | 1 | 92.47% | N/A | N/A | N/A | ||||
| ALT | ALTIMMUNE INC | $517.54M | $7.30 | $15.00 | 105.48% | Buy | 3 | 313.34% | N/A | N/A | N/A | ||||
| ITOS | ITEOS THERAPEUTICS INC | $417.93M | $11.66 | $33.33 | 185.87% | Strong Buy | 3 | 120.33% | N/A | N/A | N/A | ||||
| CDIO | CARDIO DIAGNOSTICS HOLDINGS INC | $16.56M | $0.77 | $1.35 | 76.01% | Buy | 1 | 2,539.97% | N/A | N/A | N/A | ||||
| PLRX | PLIANT THERAPEUTICS INC | $842.14M | $13.98 | $46.67 | 233.81% | Buy | 3 | 45.40% | N/A | N/A | N/A | ||||
| BGNE | BEIGENE LTD | $16.98B | $162.25 | $232.00 | 42.99% | Strong Buy | 4 | 26.07% | N/A | N/A | N/A | ||||
| SPRB | SPRUCE BIOSCIENCES INC | $30.61M | $0.74 | $5.40 | 625.81% | Buy | 5 | 84.64% | N/A | N/A | N/A | ||||
| TECH | BIO-TECHNE CORP | $12.15B | $77.29 | $80.71 | 4.43% | Strong Buy | 7 | 6.63% | 29.33% | N/A | N/A | ||||
| RVMD | REVOLUTION MEDICINES INC | $6.62B | $40.20 | $41.10 | 2.24% | Strong Buy | 10 | 47.70% | N/A | N/A | N/A | ||||
| CALT | CALLIDITAS THERAPEUTICS AB | $595.80M | $20.00 | $50.00 | 150.00% | Buy | 1 | 63.07% | N/A | N/A | N/A | ||||
| BRNS | BARINTHUS BIOTHERAPEUTICS PLC | $84.85M | $2.18 | $8.00 | 266.97% | Buy | 1 | 49.52% | N/A | N/A | N/A | ||||
| SPRY | ARS PHARMACEUTICALS INC | $940.89M | $9.75 | $18.50 | 89.74% | Buy | 2 | 1,785.77% | N/A | N/A | N/A | ||||
| EYPT | EYEPOINT PHARMACEUTICALS INC | $983.66M | $19.74 | $37.75 | 91.24% | Strong Buy | 4 | N/A | N/A | N/A | N/A | ||||
| RYTM | RHYTHM PHARMACEUTICALS INC | $2.63B | $43.76 | $52.25 | 19.40% | Strong Buy | 4 | 63.39% | N/A | N/A | N/A | ||||
| APRE | APREA THERAPEUTICS INC | $29.05M | $5.35 | $15.50 | 189.72% | Buy | 2 | 0.95% | N/A | N/A | N/A | ||||
| IFRX | INFLARX NV | $81.26M | $1.38 | $8.00 | 479.71% | Buy | 1 | 799.80% | N/A | N/A | N/A | ||||
| SAGE | SAGE THERAPEUTICS INC | $838.94M | $13.94 | $19.53 | 40.12% | Hold | 15 | 49.01% | N/A | N/A | N/A | ||||
| LXRX | LEXICON PHARMACEUTICALS INC | $428.45M | $1.74 | N/A | N/A | N/A | N/A | 335.13% | N/A | N/A | N/A | ||||
| QSI | QUANTUM-SI INC | $260.86M | $1.84 | $4.00 | 117.39% | Buy | 1 | 182.41% | N/A | N/A | N/A | ||||
| IMCR | IMMUNOCORE HOLDINGS PLC | $3.00B | $60.23 | $80.88 | 34.28% | Strong Buy | 8 | 12.03% | N/A | N/A | N/A | ||||
| KRRO | KORRO BIO INC | $467.20M | $58.24 | $126.25 | 116.78% | Strong Buy | 4 | N/A | N/A | N/A | N/A | ||||
| ZLAB | ZAI LAB LTD | $1.61B | $16.25 | $59.83 | 268.20% | Strong Buy | 3 | 50.57% | N/A | N/A | N/A | ||||
| MREO | MEREO BIOPHARMA GROUP PLC | $457.24M | $3.26 | $6.50 | 99.39% | Strong Buy | 2 | 999.90% | N/A | N/A | N/A | ||||
| VCYT | VERACYTE INC | $1.53B | $20.35 | $27.33 | 34.31% | Hold | 3 | 10.33% | N/A | N/A | N/A | ||||
| VRDN | VIRIDIAN THERAPEUTICS INC | $966.62M | $15.40 | $34.43 | 123.56% | Buy | 7 | 504.64% | N/A | N/A | N/A | ||||
| IMTX | IMMATICS NV | $911.76M | $10.77 | N/A | N/A | N/A | N/A | 13.76% | N/A | N/A | N/A | ||||
| OCS | OCULIS HOLDING AG | $469.12M | $12.80 | $30.50 | 138.28% | Strong Buy | 4 | 201.96% | N/A | N/A | N/A |
Biotech Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.